Global Primary Biliary Cirrhosis Drug Market Analysis 2016-2020 and Forecast 2021-2026
March 2021
91
About the Report
About the Report
Snapshot
The global Primary Biliary Cirrhosis Drug market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Primary Biliary Cirrhosis Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Johnson & Johnson
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Clinic
Hospital
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Products
Table of Contents
Table of Contents
Table of Contents
1 Industry Overview
1.1 Primary Biliary Cirrhosis Drug Industry
Figure Primary Biliary Cirrhosis Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Primary Biliary Cirrhosis Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Primary Biliary Cirrhosis Drug
1.2.2 Downstream
Table Application Segment of Primary Biliary Cirrhosis Drug
Table Global Primary Biliary Cirrhosis Drug Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Primary Biliary Cirrhosis Drug Market by Type
3.1 By Type
3.1.1 Budesonide
Table Major Company List of Budesonide
3.1.2 FFP-104
Table Major Company List of FFP-104
3.1.3 GSK-2330672
Table Major Company List of GSK-2330672
3.1.4 MBX-8025
Table Major Company List of MBX-8025
3.1.5 NGM-282
Table Major Company List of NGM-282
3.1.6 Others
Table Major Company List of Others
3.2 Market Size
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Type, in USD Million
Figure Global Primary Biliary Cirrhosis Drug Market Growth 2016-2020, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Type, in Volume
Figure Global Primary Biliary Cirrhosis Drug Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 AlbireoPharma (Company Profile, Sales Data etc.)
4.1.1 AlbireoPharma Profile
Table AlbireoPharma Overview List
4.1.2 AlbireoPharma Products & Services
4.1.3 AlbireoPharma Business Operation Conditions
Table Business Operation of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 CymaBay Therapeutics, Inc. (Company Profile, Sales Data etc.)
4.2.1 CymaBay Therapeutics, Inc. Profile
Table CymaBay Therapeutics, Inc. Overview List
4.2.2 CymaBay Therapeutics, Inc. Products & Services
4.2.3 CymaBay Therapeutics, Inc. Business Operation Conditions
Table Business Operation of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Dr. Falk Pharma GmbH (Company Profile, Sales Data etc.)
4.3.1 Dr. Falk Pharma GmbH Profile
Table Dr. Falk Pharma GmbH Overview List
4.3.2 Dr. Falk Pharma GmbH Products & Services
4.3.3 Dr. Falk Pharma GmbH Business Operation Conditions
Table Business Operation of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Enanta Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.4.1 Enanta Pharmaceuticals, Inc. Profile
Table Enanta Pharmaceuticals, Inc. Overview List
4.4.2 Enanta Pharmaceuticals, Inc. Products & Services
4.4.3 Enanta Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.5.1 GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Overview List
4.5.2 GlaxoSmithKline Plc Products & Services
4.5.3 GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Intercept Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.6.1 Intercept Pharmaceuticals, Inc. Profile
Table Intercept Pharmaceuticals, Inc. Overview List
4.6.2 Intercept Pharmaceuticals, Inc. Products & Services
4.6.3 Intercept Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Johnson & Johnson (Company Profile, Sales Data etc.)
4.7.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.7.2 Johnson & Johnson Products & Services
4.7.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 MediGene AG (Company Profile, Sales Data etc.)
4.8.1 MediGene AG Profile
Table MediGene AG Overview List
4.8.2 MediGene AG Products & Services
4.8.3 MediGene AG Business Operation Conditions
Table Business Operation of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 NGM Biopharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.9.1 NGM Biopharmaceuticals, Inc. Profile
Table NGM Biopharmaceuticals, Inc. Overview List
4.9.2 NGM Biopharmaceuticals, Inc. Products & Services
4.9.3 NGM Biopharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Virobay Inc. (Company Profile, Sales Data etc.)
4.10.1 Virobay Inc. Profile
Table Virobay Inc. Overview List
4.10.2 Virobay Inc. Products & Services
4.10.3 Virobay Inc. Business Operation Conditions
Table Business Operation of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Primary Biliary Cirrhosis Drug Sales Revenue 2016-2020, by Company, in USD Million
Table Global Primary Biliary Cirrhosis Drug Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Primary Biliary Cirrhosis Drug Sales Revenue Share in 2020, by Company, in USD Million
Table Global Primary Biliary Cirrhosis Drug Sales Volume 2016-2020, by Company, in Volume
Table Global Primary Biliary Cirrhosis Drug Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Primary Biliary Cirrhosis Drug Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Primary Biliary Cirrhosis Drug Market Concentration, in 2020
Figure Europe Primary Biliary Cirrhosis Drug Market Market Concentration, in 2020
Figure Asia-Pacific Primary Biliary Cirrhosis Drug MMarket Concentration, in 2020
Figure South America Primary Biliary Cirrhosis Drug Market Concentration, in 2020
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Clinic
Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2016-2020, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2016-2020, in Volume
6.1.2 Demand in Hospital
Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2016-2020, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Primary Biliary Cirrhosis Drug Demand in Others, 2016-2020, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Primary Biliary Cirrhosis Drug Demand Forecast 2021-2026, by Application, in USD Million
Figure Primary Biliary Cirrhosis Drug Market Growth 2021-2026, by Application, in USD Million
Figure Primary Biliary Cirrhosis Drug Market Share in 2026, by Application, in USD Million
Table Primary Biliary Cirrhosis Drug Demand Forecast 2021-2026, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Market Growth 2021-2026, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Primary Biliary Cirrhosis Drug Production 2016-2020, by Region, in USD Million
Table Primary Biliary Cirrhosis Drug Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Share 2016-2020, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Region, in Volume
Table Global Primary Biliary Cirrhosis Drug Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table North America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table Europe Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table South America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Region, in USD Million
Table Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Figure
List of Figure
1. Figure Primary Biliary Cirrhosis Drug Industry Chain Structure
2. Figure Global Primary Biliary Cirrhosis Drug Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Primary Biliary Cirrhosis Drug Market Growth 2016-2020, by Type, in Volume
4. Figure Global Primary Biliary Cirrhosis Drug Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Primary Biliary Cirrhosis Drug Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Primary Biliary Cirrhosis Drug Market Concentration, in 2020
7. Figure Europe Primary Biliary Cirrhosis Drug Market Market Concentration, in 2020
8. Figure Asia-Pacific Primary Biliary Cirrhosis Drug MMarket Concentration, in 2020
9. Figure South America Primary Biliary Cirrhosis Drug Market Concentration, in 2020
10. Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Concentration, in 2020
11. Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2016-2020, in USD Million
12. Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2016-2020, in Volume
13. Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2016-2020, in USD Million
14. Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2016-2020, in Volume
15. Figure Primary Biliary Cirrhosis Drug Demand in Others, 2016-2020, in USD Million
16. Figure Primary Biliary Cirrhosis Drug Demand in Others, 2016-2020, in Volume
17. Figure Primary Biliary Cirrhosis Drug Market Growth 2021-2026, by Application, in USD Million
18. Figure Primary Biliary Cirrhosis Drug Market Share in 2026, by Application, in USD Million
19. Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
20. Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
21. Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
25. Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
26. Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview
List of Table
List of Table
1. Table Upstream Segment of Primary Biliary Cirrhosis Drug
2. Table Application Segment of Primary Biliary Cirrhosis Drug
3. Table Global Primary Biliary Cirrhosis Drug Market 2016-2026, by Application, in USD Million
4. Table Major Company List of FFP-104
5. Table Major Company List of GSK-2330672
6. Table Major Company List of MBX-8025
7. Table Major Company List of NGM-282
8. Table Major Company List of Others
9. Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Type, in USD Million
10. Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Type, in Volume
11. Table Global Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Type, in USD Million
12. Table Global Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Type, in Volume
13. Table AlbireoPharma Overview List
14. Table Business Operation of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table CymaBay Therapeutics, Inc. Overview List
16. Table Business Operation of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Dr. Falk Pharma GmbH Overview List
18. Table Business Operation of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Enanta Pharmaceuticals, Inc. Overview List
20. Table Business Operation of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table GlaxoSmithKline Plc Overview List
22. Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Intercept Pharmaceuticals, Inc. Overview List
24. Table Business Operation of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Johnson & Johnson Overview List
26. Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table MediGene AG Overview List
28. Table Business Operation of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table NGM Biopharmaceuticals, Inc. Overview List
30. Table Business Operation of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table Virobay Inc. Overview List
32. Table Business Operation of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Global Primary Biliary Cirrhosis Drug Sales Revenue 2016-2020, by Company, in USD Million
34. Table Global Primary Biliary Cirrhosis Drug Sales Revenue Share 2016-2020, by Company, in USD Million
35. Table Global Primary Biliary Cirrhosis Drug Sales Volume 2016-2020, by Company, in Volume
36. Table Global Primary Biliary Cirrhosis Drug Sales Volume Share 2016-2020, by Company, in Volume
37. Table Regional Demand Comparison List
38. Table Major Application in Different Regions
39. Table Primary Biliary Cirrhosis Drug Demand Forecast 2021-2026, by Application, in USD Million
40. Table Primary Biliary Cirrhosis Drug Demand Forecast 2021-2026, by Application, in Volume
41. Table Primary Biliary Cirrhosis Drug Market Growth 2021-2026, by Application, in Volume
42. Table Primary Biliary Cirrhosis Drug Market Share in 2026, by Application, in Volume
43. Table Primary Biliary Cirrhosis Drug Production 2016-2020, by Region, in USD Million
44. Table Primary Biliary Cirrhosis Drug Production 2016-2020, by Region, in Volume
45. Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Region, in USD Million
46. Table Global Primary Biliary Cirrhosis Drug Market Share 2016-2020, by Region, in USD Million
47. Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Region, in Volume
48. Table Global Primary Biliary Cirrhosis Drug Market Share 2016-2020, by Region, in Volume
49. Table North America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
50. Table North America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
51. Table Europe Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
52. Table Europe Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
53. Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
54. Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
55. Table South America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
56. Table South America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
57. Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
58. Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
59. Table Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Region, in USD Million
60. Table Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Region, in Volume
61. Table Price Factors List
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.